Agenda for the March 2024 PBAC meeting – 22 November 2023
Page last updated: 22 November 2023
The agenda for the March 2024 PBAC meeting is now available. Your comments are welcome whether you are a patient, carer, member of the public, health professional or member of a consumer interest group. The company applying for subsidy under the Pharmaceutical Benefits Scheme has already provided the PBAC with detailed clinical and economic data in support of the application. You are welcome to provide comments, for consideration by the PBAC, from a personal or group perspective on the impact of the condition addressed in the application. Further information about the PBAC process and how to provide input can be found on the Office of Health Technology Assessment (OHTA) Consultation Hub.
Comments received for the initial PBAC consideration of the Early Re-entry resubmission items have been retained; there is no need to resubmit your comment.